Dopamine receptor ligands and imaging agents
First Claim
Patent Images
1. A compound selected from the group consisting of compounds of the formula ##STR14## where Y and Y'"'"' are independently selected from the group consisting of hydrogen C1 -C5 alkyl, C1 -C5 alkenyl and C1 -C5 alkynyl groups;
- Z is selected from the group consisting of H, Halogen (Hal), C═
CH--Hal;
C1 -C10 alkylene-Hal;
C1 -C10 alkylene--C═
CH--Hal;
C1 -C10 alkylene-phenyl-Hal;
or C1-C10 alkylene-heteroaryl-hal;
Hal is selected from the group consisting of I, 123 I, 125 I and 131 I; and
A is an alkylene moiety of from two to eight carbon atoms.
1 Assignment
0 Petitions
Accused Products
Abstract
Novel CNS dopamine D-2 receptors, such as the compound 5-iodo-7-N-[(1-ethyl-2-pyrrolidinyl)methyl]carboxamide-2,3-dihydrobenzofuran, are disclosed. These compounds are useful as imaging agents for D-2 receptors in the human brain and exhibit good brain retention and in vivo stability.
30 Citations
8 Claims
-
1. A compound selected from the group consisting of compounds of the formula ##STR14## where Y and Y'"'"' are independently selected from the group consisting of hydrogen C1 -C5 alkyl, C1 -C5 alkenyl and C1 -C5 alkynyl groups;
-
Z is selected from the group consisting of H, Halogen (Hal), C═
CH--Hal;
C1 -C10 alkylene-Hal;
C1 -C10 alkylene--C═
CH--Hal;
C1 -C10 alkylene-phenyl-Hal;
or C1-C10 alkylene-heteroaryl-hal;Hal is selected from the group consisting of I, 123 I, 125 I and 131 I; and A is an alkylene moiety of from two to eight carbon atoms. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
Specification